← Leaderboards
Robert W Carlson
Stanford University
$452,097
Attributed
$452,097
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$452,097 · 6
By mechanism
M01$452,097 · 6
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Marcia L Stefanick$20,009,558
- David K Stevenson$13,604,013
- Abby C King$27,534,373
- Mark M Davis$39,722,191
- Michaela Kiernan$5,473,113
Others in their field
Top investigators on “Breast Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$251,848,784
- Richard L Schilsky · University Of Chicago$110,812,897
- Walter John Curran · Thomas Jefferson University$96,881,565
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$87,504,493
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,613,341
Research focus
Breast NeoplasmsHuman Therapy EvaluationClinical ResearchHuman SubjectFemaleCombination Cancer TherapyNeoplasm /Cancer Relapse /RecurrenceNeoplasm /Cancer Photoradiation TherapyPhotosensitizing AgentsCarotenoidsNeoplasm /Cancer Nutrition TherapyClinical TrialsInjection /InfusionQuality Of LifeNutrition Aspect Of CancerNutrition Related TagCancer PreventionDietary FiberNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Radiation TherapyMetastasisCarcinogenesis InhibitorNeoplasm /Cancer ChemotherapyDrug Screening /Evaluation
Grant awards (14)
STUDY OF TAMOXIFEN &RALOXIFENE (STAR) FOR PREVENTION OF BREAST CANCER$334
M01 · FY2005 · RR
Women's Healthy Eating and Living Trial in the Bay Area$39,114
M01 · FY2004 · RR
Study of Tamoxifen &Raloxifene (STAR) for Breast Cancer$6,519
M01 · FY2004 · RR
Lutrin &Far Red Light in Treatment of Breast Cancer$296
M01 · FY2004 · RR
THERATOPE VACCINE FOR METASTATIC BREAST CANCER$134,676
M01 · FY2001 · RR
WOMEN'S HEALTHY EATING AND LIVING TRIAL IN THE BAY AREA$134,676
M01 · FY2001 · RR
PHASE II TRIAL OF PCI-0123 INJECTION IN RECURRENT BREAST CANCER$134,676
M01 · FY2001 · RR
PHASE II TRIAL OF PCI-0123 INJECTION IN RECURRENT BREAST CANCER$0
M01 · FY2001 · RR
WOMEN'S HEALTHY EATING AND LIVING TRIAL IN THE BAY AREA$0
M01 · FY2001 · RR
THERATOPE VACCINE FOR METASTATIC BREAST CANCER$0
M01 · FY2001 · RR
WOMEN'S HEALTHY EATING AND LIVING TRIAL IN THE BAY AREA$602
M01 · FY2000 · RR
PHASE II TREATMENT OF LUTETIUM TEXAPHYRIN INJECTION IN RECURRENT BREAST CANCER$602
M01 · FY2000 · RR
PHASE II TRIAL OF PCI-0123 INJECTION IN RECURRENT BREAST CANCER$602
M01 · FY2000 · RR
THERATOPE VACCINE FOR METASTATIC BREAST CANCER$0
M01 · FY2000 · RR